WallStreetZenWallStreetZen

NYSE: ANRO
Alto Neuroscience Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

ANRO past revenue growth

How has ANRO's revenue growth performed historically?
Company
N/A
Industry
144.63%
Market
17.55%
ANRO's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ANRO's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

ANRO earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$36.3M
Current Profit Margin
0%

ANRO Return on Equity

Insufficient data to display

Be the first to know when ANRO announces earnings.

ANRO Return on Assets

Current Company
-52.8%
Current Industry
2.9%
ANRO is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ANRO Return on Capital Employed

Current Company
-43.12%
Current Industry
19.5%

ANRO vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ANRO$0.00-$34.28M-$36.31M-100.00%N/A
CBUS$1.82M-$244.57M-$267.63M+50.41%N/A
MREO$10.00M-$27.34M-$29.47M-53.16%N/A
NGNE$0.00-$32.35M-$36.32M-100.00%N/A
ADPT$170.28M-$182.30M-$225.25M+25.06%N/A
View Top Biotech Stocks

Alto Neuroscience Earnings & Revenue FAQ

What were ANRO's earnings last quarter?

Alto Neuroscience (NYSE: ANRO) reported Q4 2023 earnings per share (EPS) of -$2.98, up 42.58% year over year. Total Alto Neuroscience earnings for the quarter were -$11.22 million. In the same quarter last year, Alto Neuroscience's earnings per share (EPS) was -$2.09.

If you're new to stock investing, here's how to buy Alto Neuroscience stock.

What was ANRO's earnings growth in the past year?

As of Q2 2024, Alto Neuroscience's earnings has grown year over year. Alto Neuroscience's earnings in the past year totalled -$36.31 million.

What was ANRO's revenue last quarter?

Alto Neuroscience (NYSE: ANRO) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Alto Neuroscience's revenue was $0.00.

What was ANRO's revenue growth in the past year?

As of Q2 2024, Alto Neuroscience's revenue has grown null year over year. Alto Neuroscience's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.